In patients with sudden transient loss of consciousness, accident and emergency departments begin by looking for a cardiac or a neurological explanation. Occasionally the cause proves to be one of the rare conditions that produce severe hypotension through vasodilatation.
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CASE HISTORY
An Asian man aged 50 was found by his work colleagues unconscious with laboured breathing, but recovered spontaneously. In the preceding two weeks he had experienced two episodes of sweating and weakness, each lasting a few minutes, without loss of consciousness. He had type 2 diabetes treated with diet alone and was taking amlodipine 5 mg daily for hypertension. There was a family history of type 2 diabetes. He consumed half a bottle of whisky a day and was an ex-smoker.
On examination he was fully conscious and normotensive, with a tachycardia. He had bilateral parotid enlargement, greater on the right than the left, and wasting of proximal limb muscles without demonstrable weakness; these signs were attributed to alcohol. Arcus senilis was present. On the electrocardiogram there was sinus tachycardia with ST depression in the lateral leads. The haemoglobin was 15.9 g/dL, white blood count 20.9610 9 /L with neutrophilia, and platelet count 225610 9 /L. He was mildly hypokalaemic (3.2 mmol/L); random glucose was 20.7 mmol/L. Tests that gave normal results included serial cardiac enzymes, creatinine, liver function tests, bone pro®le, thyroid function tests, lipid pro®le, erythrocyte sedimentation, exercise electrocardiography, 24-hour Holter monitoring, echocardiography and coronary angiography.
After coronary angiography, however, he complained of palpitations and of feeling hot and sweaty. He was observed to have bloodshot eyes, sinus tachycardia (rate 140/min) and hypotension (systolic blood pressure 60 mmHg). Symptoms and signs resolved within 30 minutes. On continuous electrocardiographic monitoring for several days no arrhythmias were seen. A further episode of hypotension and sinus tachycardia occurred in the presence of medical staff, during which initially there was no palpable cardiac output and he had a grand mal seizure. Central venous access was achieved, but recovery was spontaneous. During a third episode, central venous pressure, measured via the right internal jugular line, proved to be low during the period of hypotension and sinus tachycardia, pointing to a primary vasodilatory mechanism.
A full septic screen was negative. The initial neutrophilia had resolved. Amlodipine was discontinued. Autonomic function tests were normal. Although mild hypokalaemia was recorded during two attacks he was normokalaemic at other times. Screening tests for rare conditions associated with the episodic release of vasodilatory mediators were performed. Urinary 5-hydroxyindoleacetic acid concentrations, urinary catecholamine concentrations, and serum calcitonin concentrations and gut neuropeptide concentrations (vasoactive intestinal peptide, pancreatic polypeptide, gastrin, glucagon, neurotensin, somatostatin) were normal, excluding respectively the carcinoid syndrome, phaeochromocytoma, medullary carcinoma of the thyroid and vasoactive intestinal peptide producing tumour. Urinary methylhistamine concentrations were, however, repeatedly high (57±115 ng/mL; normal range 5±20). There were no skin lesions and a skin biopsy showed no increase in mast cell in®ltrate, but bone marrow aspirate and trephine biopsy were diagnostic of systemic mastocytosis (see Figures 1 and  2) . Effective relief of symptoms has been achieved over a period of months with loratadine and ranitidine to block H 1 and H 2 receptors, respectively, and high-dose aspirin to block production of prostaglandin D 2 .
COMMENT Systemic mastocytosis is a myeloproliferative disorder probably resulting from mutation of a multipotent haemopoietic stem cell 1 . Mast cells proliferate abnormally in the bone marrow and other organs. In cutaneous mastocytosis, abnormal mast cell proliferation is localized to the skin and results in a characteristic skin lesion called urticaria pigmentosa, whereas in systemic mastocytosis urticaria pigmentosa is seldom present. Hepatomegaly, splenomegaly, lymphadenopathy, bone pain (and pathological fractures) and hypersplenism have all been reported. Patients often have symptoms related to the episodic release of mast cell mediators such as histamine and prostaglan-dinsÐ¯ushing, alcohol intolerance, diarrhoea, bronchospasm, heat or cold intolerance, headache 2 . Symptomatic release of mast cell granules can be precipitated by exposure to alcohol, aspirin, opioids, anticholinergics, non-steroidal anti-in¯ammatory drugs and contrast media.
Although the outcome is often determined by evolution of the myeloproliferative clone, the release of vasodilatory mediators can produce life-threatening reactions 3 . Histamine effects can be blocked with a combination of H 1 and H 2 receptor antagonists. The addition of high-dose aspirin has been observed to ameliorate symptoms which persist despite the administration of H 1 and H 2 receptor antagonists 4 ; but, since aspirin may precipitate release of mast cell granule contents, this drug should be introduced cautiously. Oral disodium cromoglycate has also been reported bene®cial 5 .
The underlying myeloproliferative process does not respond well to treatment. Alpha-interferon has been useful in some patients 6 . High-dose chemotherapy followed by allogeneic bone marrow transplantation has been attempted in one case, with relapse after only four months 7 . Since the patient described here has remained well, he has not received any therapy for the underlying process.
Because of its diverse manifestations, systemic mastocytosis can present to many different specialists. The patient described here was seen by ®ve teams of physicians before the cause of his attacks was identi®ed. 
